https://orcid.org/0000-0002-4916-4976
References
- Katerenchuk IP, Tkachenko LA, Yarmola TI, et al. Churg–Strauss syndrome: clinical case and its feautures. Wiad Lek. 2019;72(4):723–726.31055564
- Bychkov VG, Zolotukhin VM, Khadieva ED, et al. Hypereosinophilic syndrome, cardiomyopathies, and sudden cardiac death in superinvasive opisthorchiasis. Cardiol Res Pract. 2019;4836948.31210984
- Iriyama N, Takahashi H, Naruse H, et al. A novel fusion gene involving PDGFRB and GCC2 in a chronic eosinophilic leukemia patient harboring t(2;5)(q37;q31). Mol Genet Genomic Med. 2019;7(4):e0059. doi:10.1002/mgg3.591
- Leru PM. Eosinophilic disorders: evaluation of current classification and diagnostic criteria, proposal of a practical diagnostic algorithm. Clin Transl Allergy. 2019;9:36. doi:10.1186/s13601-019-0277-431367340
- Wallace KL, Elias MK, Butterfield CL, Weiler L. Hypereosinophilic syndrome and thrombosis: a retrospective review. J Allergy Clin Immunol. 2013;131(Supplement):441. doi:10.1016/j.jaci.2012.12.1105
- Li D, Xu L, Lin D, Jiang S, Feng S, Zhu L. Acute pulmonary embolism and deep vein thrombosis secondary to idiopathic hypereosinophilic syndrome. Respir Med Case Rep. 2018;25:213–215. doi:10.1016/j.rmcr.2018.09.00630237972
- Gharaibeh L, Albsoul-Younes A, Younes N. Evaluation of VTE prophylaxis in an educational hospital: comparison between the institutional guideline (Caprini 2006) and the ACCP guideline (Ninth edition). Clin Appl Thromb Hemost. 2016;22(7):627–632. doi:10.1177/107602961557534425753966
- Tefferi A, Gotlib J, Pardanani A. Hypereosinophilic syndrome and clonal eosinophilia: point-of-care diagnostic algorithm and treatment update. Mayo Clin Proc. 2010;85(2):158–164. doi:10.4065/mcp.2009.050320053713
- Naito T, Hayashi H, Kashiwada T, et al. Pulmonary embolism and deep vein thrombosis in eosinophilic granulomatosis with polyangiitis successfully treated with rivaroxaban. Respir Med Case Rep. 2018;25:33–35. doi:10.1016/j.rmcr.2018.05.00829998056
- Neto Neves EM, Sousa Santos SO, Ferraz KC, et al. Matrix metalloproteinase inhibition attenuates right ventricular dysfunction and improves responses to dobutamine during acute pulmonary thromboembolism. J Cell Mol Med. 2013;17:1588–1597. 24199964
- Querques F, Cantilena B, Cozzolino C,et al. Angiotensin I receptor stimulates osteoprogenitor proliferation throug TGFß-mediated signaling. J Cell Physiol. 2015;230:1466–1474.25556973
- Mukai HY, Ninomiya H, Ohtani K, Nagasawa T, Abe T. Major basic protein binding to thrombomodulin potentially contributes to the thrombosis in patients with eosinophilia. Br J Haematol. 1995;90(4):892–899. doi:10.1111/j.1365-2141.1995.tb05211.x7669668
- Torrent M, Nogués MV, Boix E. Eosinophil cationic protein (ECP) can bind heparin and other glycosaminoglycans through its RNase active site. J Mol Recognit. 2011;24(1):90–100. doi:10.1002/jmr.102720213669
- Di Micco P, Lodigiani C. Idiopathic Venous Thromboembolism (VTE) and its association to rare molecular clotting abnormalities. Health Sci J. 2018;12:e15. doi:10.21767/1791-809X